GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alimera Sciences Inc (ALIM) [hlAlert]

Alimera Sciences, Inc. is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is focused on diseases affecting the back of the eye, or retina. Its most advanced product candidate is Iluvien, which the Company is developing for the
treatment of diabetic macular edema (DME). The Company has completed enrollment of 956 patients in two Phase 3 pivotal clinical trials for the use of Iluvien in the treatment of DME across the United States, Canada, Europe and India. Iluvien is an intravitreal insert designed to provide a sustained therapeutic effect for up to 36 months by delivering a low daily dose of fluocinolone acetonide (FA), a corticosteroid with demonstrated efficacy in the treatment of ocular diseases. Iluvien is inserted into the patient?s eye with a 25-gauge needle, which allows for a self-sealing wound.
.
( Total: 5 Current Stock Recommendations )
Alimera Sciences Inc   (5)
Hold 20% Buy 80%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
12/27/2010  
Buy
  
11/14/2011  
Hold
  
10/28/2013  
Buy
  
9/29/2014  
Buy
  
11/17/2014  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy